Review article: Phenytoin use and efficacy in the ED: Review Article

EMA - Emergency Medicine Australasia

Volumn 22, Issue 2, 2010, Pages 108-118

  Gallop, Katharine ^a  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

Emergency department; Phenytoin; Seizure

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXAMETHASONE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; ISONIAZID; LITHIUM; LORAZEPAM; MAGNESIUM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; SALICYLIC ACID DERIVATIVE; THEOPHYLLINE; VALPROIC ACID;

ATAXIA; BRADYCARDIA; BRAIN ABSCESS; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG MONITORING; DRUG SOLUBILITY; ECLAMPSIA; EMERGENCY CARE; EPILEPTIC STATE; FEBRILE CONVULSION; HEART ARREST; HUMAN; HYPOTENSION; INFUSION RATE; INJECTION SITE BURNING; INJECTION SITE PAIN; LOADING DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; NAUSEA AND VOMITING; NONHUMAN; NYSTAGMUS; PREECLAMPSIA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENCE RISK; REVIEW; SEIZURE; SUBDURAL HEMATOMA; TRAUMATIC BRAIN INJURY; TRAUMATIC EPILEPSY; WITHDRAWAL SEIZURE;

ADMINISTRATION, ORAL; ADULT; ANTICONVULSANTS; AUSTRALIA; CHILD; DRUG MONITORING; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; PHENYTOIN; PREGNANCY; SEIZURES;

EID: 77951214879     PISSN: 17426731     EISSN: 17426723     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2010.01269.x     Document Type: Review

References (77)

1. Guyatt GH, Oxman AD, Gunn EV et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br. Med. J. 2008 336 : 924 926. (Pubitemid 351632017)
2. Porter RJ, Meldrum BS. Antiseizure drugs. In : Katzung BG, ed. Basic and Clinical Pharmacology.
3. Dilantin (Phenytoin sodium), Pfizer Australia Pty Ltd, 38-42 Wharf Road, West Ryde, NSW 2114, Australia. Product information leaflet.
4. Phenytoin Injection BP, DBL, Registered trademark of MaynePharma Limited, 1 Lexia Place, Mulgrave, Vic. 3170, Australia.
5. Swadron SP, Rudis MI, Azimian K, Beringer P, Fort D, Orlinsky M. A comparison of phenytoin-loading techniques in the emergency department. Acad. Emerg. Med. 2004 11 : 244 252. (Pubitemid 38364860)
6. Ratanakorn D, Kaojare S, Phuapradit P, Mokkhavesa C. Single oral loading dose of phenytoin: a pharmacokinetics study. J. Neurol. Sci. 1997 147 : 89 92. (Pubitemid 27117509)
7. Earnest MP, Marx JA, Drury LR. Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. JAMA 1983 249 : 762 765.
8. Burneo JG, Anandan JV, Barkley GL. A prospective study of the incidence of the purple glove syndrome. Epilepsia 2001 42 : 1156 1159. (Pubitemid 32947936)
9. Winter ME, Tozer TN. Phenytoin. In : Buton ME, Shaw LM, Schentag JJ, Evans WE, eds. Applied Pharmacokinetics and Pharmacodynamics: Principles of Therapeutic Drug Monitoring.
10. Louis S, Kutt H, McDowell F. The cardiocirculatory changes caused by intravenous dilantin and its solvent. Am. Heart J. 1967 74 : 525 529.
11. Wallis W, Kutt K, McDowell F. Intravenous diphenylhydantoin in the treatment of acute repetitive seizures. Neurology 1968 18 : 513 525.
12. Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 1978 28 : 874 880. (Pubitemid 8390039)
13. Vinsel PJ, Moore GP, O'Hair KC. Comparison of intraosseous versus intravenous loading of phenytoin in pigs and effect on bone marrow. Am. J. Emerg. Med. 1990 8 : 181 183.
14. Jaimovich DG, Shabino CL, Ringer TV, Peters GR. Comparison of intraosseous and intravenous routes of anticonvulsant administration in a porcine model. Ann. Emerg. Med. 1989 18 : 842 846. (Pubitemid 19194448)
15. Wilkensy AJ, Lowden JA. Inadequate serum levels after intramuscular administration of diphenylhydantoin. Neurology 1973 23 : 318.
16. Australian Injectable Drugs Handbook Fourth Edition Third Reprint Revised September 2009). Ed Nicolette Burridge. The Society of Hospital Pharmacists of Australia. 2008. Collingwood
17. Osborn HH, Zisfein J, Sparano R. Single-dose oral phenytoin loading. Ann. Emerg. Med. 1987 16 : 407 412.
18. Johnson J, Wrenn K. Inappropriate fosphenytoin use in the ED. Am. J. Emerg. Med. 2001 19 : 293 294. (Pubitemid 32642157)
19. Van der Meyden CH, Kruger AJ, Muller FO, Rabie W, Schall R. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures. Epilepsia 1994 35 : 189 194. (Pubitemid 24074485)
20. Manthey D, Barnes D. Oral vs intravenous phenytoin loading. Acad. Emerg. Med. 2003 10 : 492.
21. Binder L, Trujillo J, Parker D, Cuetter A. Association of intravenous phenytoin toxicity with demographic, clinical and dosing parameters. Am. J. Emerg. Med. 1996 14 : 398 401. (Pubitemid 26240847)
22. Andersen BB, Moller A, Gram L, Jensen NO, Dam M. Phenytoin-loading: pharmacokinetic comparison between an intravenous bolus injection and a diluted standard solution. Acta Neurol. Scand. 1992 85 : 174 176.
23. Milne DJ, Foo J, Sharley NA, Milne RW. Phenytoin infusion revisited: stability and administration. J. Pharm. Pract. Res. 2004 34 : 272 275. (Pubitemid 40223294)
24. Giacona N, Bauman JL, Siepler JK. Crystallization of three phenytoin preparations in intravenous solutions. Am. J. Hosp. Pharm. 1982 39 : 630 634. (Pubitemid 12109040)
25. Pfeifle CE, Adler DS, Gannaway WL. Phenytoin sodium soulbility in three intravenous solutions. Am. J. Hosp. Pharm. 1981 38 : 358 362.
26. Carducci B, Hedges JR, Beal JB, Levy RC, Martin M. Emergency phenytoin loading by constant IV infusion. Ann. Emerg. Med. 1984 13 : 1027 1031. (Pubitemid 15201881)
27. Spengler RF, Arrowsmith JB, Kilarski DJ, Buchanan C, Von Behren L, Graham DR. Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration factors. Arch. Intern. Med. 1988 148 : 1329 1333.
28. Gannaway WL, Wilding DC, Siepler JK, King JH, Lee-Ow A. Clinical use of intravenous phenytoin sodium infusions. Clin. Pharm. 1983 2 : 135 138. (Pubitemid 13161729)
29. York RC, Coleridge ST. Cardiopulmonary arrest following intravenous phenytoin loading. Am. J. Emerg. Med. 1988 6 : 255 259.
30. Donovan PJ, Cline D. Phenytoin administration by constant intravenous infusion: selective rates of administration. Ann. Emerg. Med. 1991 20 : 139 142.
31. Schimdt H, Belleza J, Dougherty JM, White L, Lammers R. Adverse effects with administration of phenytoin: infusion pump vs manual infusion. Acad. Emerg. Med. 1995 2 : 758 759.
32. Ault MJ. Catheter occlusion from intravenous phenytoin. Ann. Emerg. Med. 2004 44 : 428 429.
33. Buchthal F, Svensmark O. Aspects of the pharmacology of phenytoin (dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy. Epilepsia 1960 1 : 373 384.
34. Buchthal F, Svensmark O, Schiller PJ. Clinical and electroencephalographic correlations with serum levels of diphenylhydantoin. Arch. Neurol. 1960 2 : 624 630.
35. Schmidt D, Einicke I, Haenel F. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital and carbamazepine. Arch. Neurol. 1986 43 : 263 265. (Pubitemid 16117840)
36. Dasgupta A. Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management. Clin. Chim. Acta 2007 377 : 1 13. (Pubitemid 44920213)
37. Wolf GK, Mcclain CD, Zurakowski D, Dodson B, McManus ML. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children. Pediatr. Crit. Care Med. 2006 7 : 434 439. (Pubitemid 44386068)
38. Kilpatrick CJ, Wanwimolruk S, Wing LM. Plasma concentrations of unbound phenytoin in the management of epilepsy. Br. J. Clin. Pharmacol. 1984 17 : 539 546. (Pubitemid 14057460)
39. Neels HM, Sierens AC, Naelaerts K, Scharpe SL, Hatfield GM, Lambert WE. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin. Chem. Lab. Med. 2004 42 : 1228 1255. (Pubitemid 39600327)
40. Dasgupta A, Dennen DA, Dean R, McLawhon RW. Prediction of free phenytoin levels based on [total phenytoin]/[albumin] ratios. Potential erros with hypoalbuminaemia. Am. J. Clin. Pathol. 1991 95 : 253 256.
41. Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Okuda M. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding. Biopharm. Drug Dispos. 2006 27 : 77 84.
42. Meierkord H, Boon P, Engelson B et al. EFNS guideline on the management of status epilepticus. Eur. J. Neurol. 2006 13 : 445 450. (Pubitemid 43823356)
43. SIGN guidelines. 70 Diagnosis and Management of Epilepsy in Adults.
44. NICE guidelines. CG20 Epilepsy in Adults and Children: Full Guideline.
45. Leppik IE, Patrick BK, Cranford RE. Treatment of acute seizures and status epilepticus with intravenous phenytoin. Adv. Neurol. 1983 34 : 447 451.
46. Treiman DM, Meyers PD, Walton NY et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl. J. Med. 1998 339 : 792 798.
47. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst. Rev. 2005 Art No CD003723. [Cited 21 March 2010] http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/ CD003723/pdf-fs.html. (Pubitemid 46753578)
48. Mayer SA, Claassen K, Lokin K, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch. Neurol. 2002 59 : 205 210. (Pubitemid 34240935)
49. Chin RF, Neville BG, Peckham C, Wade A, Bedford H, Scott RC. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol. 2008 7 : 696 703.
50. Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988 38 : 202 207.
51. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neruology 2006 67 : 340 342. (Pubitemid 44313586)
52. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Eur. Jnl. of Epi. 2007 6 : 527 532. (Pubitemid 47209244)
53. Peters CN, Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus - experience in 102 adult patients. Seizure 2007 16 : 527 532. (Pubitemid 40425264)
54. Knake S, Hamer HJ, Rosenow F. Status epilepticus: a critical review. Epilepsy Behav. 2009 15 : 10 14.
55. Pechadre JC, Laauxerois M, Colnet G et al. Prevention of late post traumatic epilepsy by phenytoin in severe brain injuries: 2 year follow up. Presse Med. 1991 20 : 841 845.
56. Temkin NR, Dikman Ss, Wilensky AJ, Kheim J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevetion of post-traumatic seizures. N. Engl. J. Med. 1990 323 : 497 502. (Pubitemid 20260049)
57. Young B, Rapp RP, Norion JA, Haack D, Tibbs PA, Bean JR. Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J. Neurosurg. 1983 58 : 231 235. (Pubitemid 13190257)
58. Young B, Rapp RP, Norion JA, Haack D, Tibbs PA, Bean JR. Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J. Neurosurg. 1983 58 : 236 241. (Pubitemid 13190258)
59. Schierhout G. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Sys. Rev. 2001 4 : CD000173.
60. Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003 28 : 1161 1162.
61. Young KD, Okada PJ, Sokolove PE et al. A randomized, double-blinded, placebo-controlled trial of phenytoin for the prevention of early post-traumatic seizures in children with moderate to severe blunt head injury. Ann. Emerg. Med. 2004 43 : 435 446.
62. Frend V. Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant? Clin. Neuropharmacol. 2007 30 : 362 369. (Pubitemid 350307316)
63. Alldredge BK, Lowenstein DH, Simon RP. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am. J. Med. 1989 87 : 645 648.
64. Chance JF. Emergency department treatment of alcohol withdrawal seizures with phenytoin. Ann. Emerg. Med. 1991 20 : 263 271.
65. Rathlev NK, D'Onofrio G, Fish SS et al. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann. Emerg. Med. 1994 23 : 513 518. (Pubitemid 24097659)
66. Minozzi S, Amato L, Vecchi S, Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database of Systematic Reviews. 2010 3 : Art No CD005064. DOI: 10.1002/14651858.CD005064.pub3.
67. Kunisaki TA, Augentstein WL. Drug- and toxin-induced seizures. Emerg. Med. Clin. North Am. 1994 12 : 1027 1056.
68. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995 345 : 1445 1463.
69. Duley L, Henderson-Smart DJ. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Sys. Rev. 2003 4 : Art. No CD000128. DOI: 10.1002/14651858.CD000128 SA, Lim KH, Baker CA, Repke JT. Phenytoin versus magnesium sulphate in pre-eclampsia: a pilot study. Am. J. Perinatol. 1993 10 : 233 238.
70. Lucas MJ, Leveno MJ, Cunningham MD. A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia. N. Engl. J. Med. 1995 333 : 201 205.
71. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Sys. Rev. 2003 Art. No CD000025. DOI: 10.1002/14651858.CD000025.
72. Tremont-Lukats IW, Ratilal BO, Armstrong T, Gilbert MR. Antieepileptic drugs for preventing seizures in people with brain tumours. Cochrane Database Sys. Rev. 2008 2 : Art. No CD004424. DOI: 10.1002/14651858.CD004424.pub2 AM, Kreiter KT, Janjua N et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid haemorrhage. Stroke 2005 36 : 583 587. (Pubitemid 351807224)
73. Ratilal B, Costa J, Sampaio C. Anticonvulsants for preventing seizures in patients with chronic subdural haematoma. Cochrane Database Sys. Rev. 2005 3 : Art. No CD004893. DOI: 10.1002/14651858.CD004893.pub2 J, Wood E. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Sys. Rev. 2010 1 : Art. No CD005398. DOI: 10.1002/14651858. CD005398.pub2 HP Jr., Adams RJ, Brott T et al. Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischaemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003 34 : 1056 1083.
74. Hack W, Kaste M, Bogousslavsky J et al. European Stroke Initiative Executive Committee and the EUSI Writing Committee. European Stroke Initiative Recommendations for Stroke Management - update 2003. Cerebrovasc. Dis. 2003 16 : 311 337. (Pubitemid 37142462)
75. Kwan J, Gunther A. Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database Sys. Rev. 2006 CD00550120.
76. Offringa M, Newton R. Prophylactic drug management for febrile convulsions in children. Cochrane Database Sys. Rev. 2007 CD003031. (Pubitemid 351805888)
77. Rantala H, Tarka R, Uhari M. A meta-analytic review of the preventive treatment of recurrences of febrile seizures. J. Pediatr. 1997 131 : 922 925. (Pubitemid 28027622)